Lycopene inhibits ER stress and apoptosis while modulating PI3K/AKT and enhancing antioxidant and anti-apoptotic proteins
PLOS One · 2025
DOI: 10.1371/journal.pone.0339565 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Lijun Zheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nursing Department, The Fourth Affiliated Hospital of School of Medicine, Zhejiang University, Yiwu, China. Hauptthemen laut MEDLINE: Apoptosis, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, Antioxidants. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Education Department.
Abstract (Originalsprache)
Acute kidney injury (AKI) is a critical clinical syndrome with limited therapeutic options. This study investigated the renoprotective effects of lycopene, a potent antioxidant, in both in vivo and in vitro AKI models. In a murine cecal ligation and puncture (CLP)-induced sepsis-AKI model, pretreatment with lycopene (10, 20, 40 mg/kg) dose-dependently ameliorated renal histopathological damage (HE staining) and restored serum biomarkers (AST, ALT, BUN, CREA). Mechanistically, lycopene suppressed oxidative stress and apoptosis by downregulating the PI3K/Akt axis: it significantly reversed the CLP-induced upregulating of p-PI3K and p-Akt, and the pro-apoptotic proteins (Bax, Cleaved Caspase-3), while increasing Nrf 2 and SOD1. Consistent results were observed in LPS- and H₂O₂-induced cellular AKI models, where lycopene attenuated cell death and restored redox homeostasis in a dose-dependent manner. Immunofluorescence assays further validated these trends. Crucially, PI3K siRNA or cDNA transfection experiments confirmed that lycopene’s antioxidant and anti-apoptotic effects were PI3K-dependent. Our findings highlight lycopene as a promising therapeutic agent for AKI, acting via PI3K/Akt-mediated activation of Nrf 2 to counteract oxidative damage and apoptosis. This study provides novel insights into the molecular mechanisms underlying lycopene’s renoprotection and supports its potential clinical translation for sepsis or oxidative stress-associated AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nursing Department, The Fourth Affiliated Hospital of School of Medicine, Zhejiang University, Yiwu, China.
- School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau (or Macau SAR), China.
- The Core Facilities, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
ORCID-Profile: Yuchao Sun
Förderung
- Zhejiang Provincial Education Department
Zitieren
APA
Zheng, L., Zhang, H., & Sun, Y. (2025). Lycopene inhibits ER stress and apoptosis while modulating PI3K/AKT and enhancing antioxidant and anti-apoptotic proteins. PLOS One. https://doi.org/10.1371/journal.pone.0339565
Vancouver
Zheng L, Zhang H, Sun Y. Lycopene inhibits ER stress and apoptosis while modulating PI3K/AKT and enhancing antioxidant and anti-apoptotic proteins. PLOS One. 2025. doi:10.1371/journal.pone.0339565
BibTeX
@article{Zheng2025,
author = {Zheng, Lijun and Zhang, Hui and Sun, Yuchao},
title = {Lycopene inhibits ER stress and apoptosis while modulating PI3K/AKT and enhancing antioxidant and anti-apoptotic proteins},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0339565}
}
EUVIMED